NO20000107L - Ny blanding - Google Patents

Ny blanding

Info

Publication number
NO20000107L
NO20000107L NO20000107A NO20000107A NO20000107L NO 20000107 L NO20000107 L NO 20000107L NO 20000107 A NO20000107 A NO 20000107A NO 20000107 A NO20000107 A NO 20000107A NO 20000107 L NO20000107 L NO 20000107L
Authority
NO
Norway
Prior art keywords
new mixture
mixture
new
blocker
pharmaceutical composition
Prior art date
Application number
NO20000107A
Other languages
English (en)
Other versions
NO20000107D0 (no
Inventor
Paul John Cummings
Ian Frederic Tulloch
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20000107L publication Critical patent/NO20000107L/no
Publication of NO20000107D0 publication Critical patent/NO20000107D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Farmasøytisk blanding innbefattende en SSRI i hurtig frigjøringsform og en p-blokker i forsinket frigjøringsform.
NO20000107A 1997-07-11 2000-01-10 Ny blanding NO20000107D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714675.7A GB9714675D0 (en) 1997-07-11 1997-07-11 Novel composition
PCT/EP1998/004971 WO1999002142A2 (en) 1997-07-11 1998-07-07 Novel composition comprising an ssri and a beta-blocker

Publications (2)

Publication Number Publication Date
NO20000107L true NO20000107L (no) 2000-01-10
NO20000107D0 NO20000107D0 (no) 2000-01-10

Family

ID=10815744

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000107A NO20000107D0 (no) 1997-07-11 2000-01-10 Ny blanding

Country Status (26)

Country Link
EP (1) EP0996466A2 (no)
JP (1) JP2002508003A (no)
KR (1) KR20010021644A (no)
CN (1) CN1262627A (no)
AP (1) AP2000001728A0 (no)
AR (1) AR016128A1 (no)
AU (1) AU9340198A (no)
BG (1) BG104119A (no)
BR (1) BR9810996A (no)
CA (1) CA2295822A1 (no)
CO (1) CO4950552A1 (no)
DZ (1) DZ2556A1 (no)
EA (1) EA200000112A1 (no)
GB (1) GB9714675D0 (no)
HU (1) HUP0003074A3 (no)
ID (1) ID24191A (no)
IL (1) IL133869A0 (no)
MA (1) MA24604A1 (no)
NO (1) NO20000107D0 (no)
OA (1) OA11276A (no)
PE (1) PE99699A1 (no)
PL (1) PL338017A1 (no)
SK (1) SK72000A3 (no)
TR (1) TR200000074T2 (no)
WO (1) WO1999002142A2 (no)
ZA (1) ZA986138B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7417038B1 (en) 1998-10-15 2008-08-26 Imperial Innovations Limited Methods of treating cachexia
PL205109B1 (pl) 1998-11-02 2010-03-31 Elan Pharma Int Ltd Wielocząstkowa kompozycja metylofenidatu o modyfikowanym uwalnianiu i jej zastosowanie
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
ATE526950T1 (de) 1999-10-29 2011-10-15 Euro Celtique Sa Hydrocodon-formulierungen mit gesteuerter freisetzung
GB0004003D0 (en) * 2000-02-22 2000-04-12 Knoll Ag Therapeutic agents
CA2427815C (en) 2000-10-30 2007-07-10 Euro-Celtique S.A. Controlled release hydrocodone formulations
AU2005283829A1 (en) * 2004-09-17 2006-03-23 Neurocure Ltd Pindolol for the treating premenstrual syndrome and premenstrual dysphoric disorder
CN100469356C (zh) * 2006-09-08 2009-03-18 山东益康药业有限公司 复方阿替洛尔缓释片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732335C2 (de) * 1976-07-27 1983-01-20 Sandoz-Patent-GmbH, 7850 Lörrach Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
EP0759299B1 (en) * 1995-08-16 2000-04-26 Eli Lilly And Company Potentiation of serotonin response
EP0792649A1 (en) * 1996-02-29 1997-09-03 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
EA200000112A1 (ru) 2000-10-30
EP0996466A2 (en) 2000-05-03
TR200000074T2 (tr) 2000-05-22
MA24604A1 (fr) 1999-04-01
HUP0003074A3 (en) 2001-12-28
CA2295822A1 (en) 1999-01-21
ID24191A (id) 2000-07-13
AU9340198A (en) 1999-02-08
JP2002508003A (ja) 2002-03-12
KR20010021644A (ko) 2001-03-15
CN1262627A (zh) 2000-08-09
CO4950552A1 (es) 2000-09-01
WO1999002142A3 (en) 1999-04-15
PL338017A1 (en) 2000-09-25
DZ2556A1 (fr) 2003-02-15
IL133869A0 (en) 2001-04-30
SK72000A3 (en) 2000-12-11
BG104119A (en) 2000-12-29
PE99699A1 (es) 1999-12-21
GB9714675D0 (en) 1997-09-17
BR9810996A (pt) 2000-08-08
AR016128A1 (es) 2001-06-20
NO20000107D0 (no) 2000-01-10
WO1999002142A2 (en) 1999-01-21
AP2000001728A0 (en) 2000-03-31
HUP0003074A2 (hu) 2001-01-29
ZA986138B (en) 2000-01-10
OA11276A (en) 2003-07-31

Similar Documents

Publication Publication Date Title
DE60010098D1 (de) 28-epirapaloge
DE69837140D1 (de) Alginatgele mit verzögerter freisetzung
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
NO20002470L (no) Ny materialsammensetning
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
FI960889A (fi) Naftyyliyhdisteitä, välituotteita, koostumuksia ja menetelmiä
DE59709549D1 (de) Vormischbrenner
NO994003L (no) Farmasoytisk blanding
DK0900225T3 (da) Alkyl-4-silyl-phenoler og estere deraf som antiatherosklerosemidler
YU58599A (sh) Gelovi sa usporenim podržanim oslobađanjem
EE200000094A (et) Uued plokk-kopolümeerid ja nende saamine
ID20406A (id) Komposisi pewarna keluaran-rendah
NO993298L (no) Ny fremgangsmÕte
EE9900524A (et) N-triasolüül-2-indoolkarboksamiidid ja nende kasutamine CCK-A agonistidena
NO20000107L (no) Ny blanding
ID18832A (id) Komposisi insektisida
NO995796D0 (no) Ny fremgangsmåte
AP2002002547A0 (en) Calcilytic compounds.
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
BR0112600A (pt) Compostos calcilìticos
ID17640A (id) Susunan pestisida
EP1383511A4 (en) CALCILYTIC COMPOUNDS
FR2747686B1 (fr) Materiau fluorescent
NO985079L (no) Eksplosiv formulering
ITMI941305A0 (it) Procedimento per la connessione telefonica, particolarmente per conferenze telefoniche e simili

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application